The large homolog of NADPH oxidase flavoprotein LNOX2, and probably LNOX1, are flavoproteins involved in the thyroid H 2 O 2 generator. Western blot analysis of membrane proteins from normal human thyroid, using antipeptide antibodies, indicated that LNOX1,2 are 164-kDa glycoproteins and that N-glycosylated motifs account for at least 10 -20 kDa of their total apparent molecular mass. Northern blot analysis of 23 different human tissues demonstrated that LNOX2 messenger RNA (mRNA) is strongly expressed only in the thyroid gland, although blast analysis of expressed sequence tags databases indicated that LNOX genes are also expressed in some nonthyroid cells.
T HE IODINE PATHWAY comprises several steps in thyroid cells that involve 1/an iodide transport from blood to follicular lumen via the basolateral sodium/iodide (Naϩ/I-) symporter (NIS) (1, 2) , and the apical chlorideiodide porter (pendrin) (3, 4) , 2/the incorporation of iodide in tyrosyl residues of thyroglobulin (Tg) molecules at the apical pole, followed by the coupling of hormonogenic iodotyrosyl residues into thyroid hormone residues; these latter two reactions are catalyzed by the thyroid peroxidase (TPO) in the presence of H 2 O 2 (5) , and 3/Tg hydrolysis and hormone secretion (6) .
TPO has no biological activity in the absence of H 2 O 2 , which is likely to be the limiting factor for Tg iodination when iodide supply is normal (7) . The H 2 O 2 generator has been studied in porcine and human thyroid tissues and is a calcium-dependent and transmembrane system that functions by transferring electrons from NADPH to molecular oxygen (8, 9) . It comprises a flavoprotein with FAD as cofactor (10) , which possibly requires other components for its activity (11) . We recently purified a novel flavoprotein from pig thyroid tissue, which constitutes the main component of the thyroid NADPH oxidase (11, 12) . Availability of peptide microsequences permitted the cloning of porcine and of human complementary DNAs (cDNAs) encoding 1207-and 1210-amino acid proteins, respectively (12) . The encoded protein displayed a theoretical molecular mass of 138 kDa and was designated p138
Tox for p138 thyroid oxidase (12) . Its gene was mapped on human chromosome 15q15 (12) . Two cDNAs (GenBank database accession numbers AF230495 and AF 230496) encoding two flavoproteins of 1,551 (thyroid oxidase ThOX1) and 1,548 amino acids (ThOX2) have recently been cloned from human thyroid tissue (13) . Expression of both genes was up-regulated by cAMP in cultured human thyrocytes. Human p138
Tox corresponds to the carboxyl fragment of human ThOX2, lacking the first 338 residues. ThOX1 is identical to the previously cloned dualoxidase Duox1 (GenBank accession number AF213465), and its sequence is 83% similar to ThOX2. Whether ThOX1/ Duox1 participates to the Ca 2ϩ /NADPH-dependent H 2 O 2 generator in thyroid tissue is still unknown. The C-terminal region of these novel proteins is very similar to the flavoproteins of the NOX family (14 -16) . Although strongly expressed in thyrocytes, these membrane flavoproteins are not absolutely thyroid-specific, and the designations "thyroid oxidase", "p138
Tox ", and "ThOX" are therefore inadequate (17) . Because ThOX/Duox flavoproteins constitute a new family of long homologs of the NOX flavoproteins and probably form a part of NADPH:O 2 -oxidoreductase systems, we will call them LNOX (large NOX) rather than Duox and/or ThOX (17) . The present study was designed to analyze LNOX gene and protein expression in normal human thyroid tissue and in a series of thyroid tissues from patients with benign diseases, in which we already studied Tg, TPO, NIS, and PDS gene expression (18, 19) . To this aim, we developed a realtime kinetic quantitative PCR to analyze gene expression (19) , and we used an immunohistochemical method based on antipeptide antibodies to detect proteins (18) .
Materials and Methods

Northern blot analysis
The full coding sequence of the human p138
Tox cDNA, corresponding to nucleotides 1015-3633 in the coding sequence of human LNOX2, was radiolabeled with [
32 P]␣-deoxycycidine triphosphate by random priming extension and separated from unincorporated nucleotides by filtration on G-50 Sephadex column. Hybridization of the LNOX2 and actin probes to three human Multiple Tissue Northern Blots, and membrane washing, were made according to the manufacturer's instructions (CLONTECH Laboratories, Inc.). Detection of signals was performed by Electronic Autoradiography using a Packard Instant Imager (Packard Instrument Company, Meriden, CT).
Peptide synthesis, production, and characterization of antipeptide antisera to LNOX2
An antipeptide rabbit polyclonal antibody was produced, tested by enzyme-linked immunosorbent assay (ELISA), and purified by Eurogentec (Seraing, Belgium). A 14-amino acid peptide encompassing the L 410 -T 423 portion of LNOX2 (LRDYWPGPGKFSRT) was synthesized by a conventional solid-phase method. For control experiments, the V 404 -T 417 homologous peptide of LNOX1 (VRDFWPGPLKFSRT) was also synthesized by the same method. The purity and identity of peptides were verified by reverse phase-high-performance liquid chromatography and mass spectrometry. The L 410 -T 423 LNOX2 peptide was conjugated to keyhole limpet hemocyanine on a cysteine residue added to the C-terminal threonine. Two rabbits were immunized by intradermal injections of the synthetic peptide-carrier conjugate. After two boosts at 4-week intervals, animals were bled, and their sera specimens were tested in an ELISA. Antisera, at various dilutions, were verified for their capacity to react with the L 410 -T 423 -LNOX2 and with the V 404 -T 417 homologous peptide of LNOX1 (100 ng in PBS) coated (4 C, 16 h) on microtiter plates. Antibody binding was then revealed by peroxidase-labeled antirabbit antibody (1:1000 dilution). Both animals produced antisera that were reactive in the ELISA assay. Antiserum with the highest affinity for the peptide, which was approximately 2 ϫ 10 Ϫ7 mol/L as determined in the competitive inhibition experiment, was purified by affinity chromatography (EAH-Sepharose coupled to the peptide). The purity estimated by SDS-PAGE was higher than 80%. ELISA assay showed that purified antiserum, obtained after immunization with the L 410 -T 423 LNOX2 synthetic peptide-carrier conjugate, also reacted with the homologous V 404 -T 417 LNOX1 synthetic peptide. The concentration of the nondiluted purified antibody was 0.7 mg/mL. CCT TGG GGC CTC TGG AAT T Probe FAM-AGC AGC GTG GTG AAG GCG GAG C-TAMRA
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Western blot
Cos-7 cells were transiently transfected using the FuGENE 6 (Roche Molecular Biochemicals, Meylan, France) according to the manufacturer's instructions. Transfected cells were incubated for 48 h, harvested, washed, and directly solubilized in SDS-PAGE sample buffer. Partially purified particulate fraction from thyroid tissue was prepared by differential centrifugation as previously described (9) .
Deglycosylation of membrane protein.
Particulate fraction (200 g) was treated for 10 min at 37 C in 50 mmol/L phosphate buffer, pH 7.4 (60 L final vol) containing the antiprotease cocktail, 2.5 mmol/L EDTA, 0.1% SDS, before the addition of 10 U/mL N-glycosidase F (1 365 169; Roche Molecular Biochemicals). After a first incubation for 1 h, 10 or 25 U/mL N-glycosidase F was added again, and the incubation was prolonged for 1 h. Controls were performed without N-glycosidase F. The reaction was stopped by adding 1 vol of gel loading buffer (60 L), and the samples were incubated overnight, at room temperature, before electrophoresis.
SDS-PAGE and immunoblot analysis.
Protein samples (25 g) were boiled for 2 min in sample buffer (2% SDS, 5% ␤-mercaptoethanol and 10% glycerol) and were subjected to SDS-PAGE (19) using a 4 -12% linear gradient acrylamide slab minigel (Invitrogen Corporation/Novex, Carlsbad, CA) and electrotransferred (20) to 0.2 m Protan BA 83 nitrocellulose sheets (Schleicher & Schuell, Inc., Ecquevilly, France) for immunodetection. Immunodetection of LNOX1,2 was achieved by preincubating membrane in TBS containing 5% fat free dry milk, and 0.1% Tween for 2 h at room temperature, and then overnight with the purified antipeptide antibody (1:1000 dilution, i.e. 0.7 g/mL) in TBS with 1.5% milk, 0.1% Tween buffer, and 0.5 mmol/L dithiothreitol, with or without 10 g/mL peptide. Antigen antibody complexes were detected using goat antirabbit IgG conjugated to alkaline phosphatase (Promega Corp., Madison, WI) and bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium (Sigma, St. Louis, MO).
Tissue samples
Thyroid tissue samples were selected after histological examination and classified according to World Health Organization recommendations (21) . Tissue samples selected for real-time quantitative PCR were as follows: normal tissues (n ϭ 5), multinodular goiters (n ϭ 5), hyperfunctioning tissues, including Graves' thyroid tissues (n ϭ 5) and toxic adenomas (n ϭ 8), and benign hypofunctioning follicular adenomas (n ϭ 24). Specimens were frozen at Ϫ80 C in isopentane and stored in liquid nitrogen before use. Except for the patients with Graves' disease or toxic adenoma, in whom serum TSH was undetectable, thyroid samples were obtained from euthyroid subjects whose serum TSH concentrations were in the normal range at the time of surgery.
Immunohistochemistry
Immunohistochemistry was performed on Duboscq-Brasil-fixed, paraffin-embedded tissues blocks of 30 thyroid samples, selected from the above series, and including normal thyroid samples (n ϭ 5), multinodular goiters (n ϭ 5), Graves' thyroid tissues (n ϭ 4), toxic adenomas (n ϭ 4), and hypofunctioning benign adenomas (n ϭ 12, including 2 Hü rthle cell adenomas). Briefly, 5-m sections were initially deparaffinized by serial passages in xylene and in alcohol series. Endogenous peroxidase Database and accession number of EST identical or highly similar to the 3Ј untranslated region of LNOX1 and LNOX2 mRNA.
activity was quenched by incubation in 0.03% of hydrogen peroxide, in 0.1 mol/L Tris-HCl buffer 1X (pH 7.6) for 5 min. Subsequently, microwave/pressure cooker pretreatment (three cycles of 5 min each) was performed in 1 mmol/L EDTA buffer (pH 8).
Sections were subsequently incubated for 30 min at room temperature with the anti-LNOX antiserum (1:25 dilution) or the anti-NIS antiserum (1:50 dilution). Sections were then washed three times in Tris-HCl 1X buffer for 5 min each time and incubated with a peroxidaseconjugated goat antirabbit antibody for 15 min (DAKO Corp., Carpinteria, CA). After three further washes, peroxidase staining was revealed in diaminobenzidine tetrahydrochloride (Polysciences Inc, Warrington, PA) with 0.1% of hydrogen peroxide, in Tris buffer, 0.01 mol/L (pH 7.2). Sections were counterstained with hematoxylin, dehydrated, and mounted. Negative controls were obtained by studying nonthyroid tissues and by studying thyroid tissues incubated with preimmune antisera and immune sera preabsorbed with an excess of the corresponding peptide. The percentage of positively stained cells was assessed semiquantitatively by light microscopy observation. Two pairs of oligonucleotide primers were designed to be, respectively, LNOX1-and LNOX2-specific and intron-spanning, using the computer program Primer Express (Perkin-Elmer Corp. PE Applied Biosystems). TaqMan probe sequence was designed to hybridize to a 100% identical region of LNOX1 and LNOX2 cDNA. They were purchased from Perkin-Elmer Corp. PE Applied Biosystems, and their sequences are presented in Table 1 . PCR reaction was carried out to produce amplicons that were subsequently analyzed by gel electrophoresis and sequencing. differences in the amount of total RNA added to the reaction, amplification of 18S ribosomal RNA was performed as an endogenous control. Primers and probes for 18S RNA were purchased from Perkin-Elmer Corp. PE Applied Biosystems. The mRNA content of each target gene was simultaneously determined in a one-run assay.
Standard curves for the LNOX1 and LNOX2 genes and 18S ribosomal RNA were constructed from PCR of calibrator cDNA strand serially diluted in nuclease-free H 2 O. The efficiency of the standard curves, as determined by their slope, allowed us to quantify the LNOX1 and LNOX2 gene expression profiles in each thyroid specimen by using the comparative threshold cycle method, according to the manufacturer's instructions. The calibrator was constituted from one sample of normal tissue: it was used as the 1ϫ sample, and all other levels were expressed as an n-fold difference relative to the calibrator. The intraassay coefficient of variation was less than 1%. PCR control experiments, performed with each LNOX cDNA as template and with each pair of primers designed to be LNOX1-or LNOX2-specific, showed no interference of LNOX1 cDNA in quantification of LNOX2 cDNA, and vice versa.
Statistical methods
The expression of LNOX genes detected in each histological type was compared with that found in normal samples. mRNA expression patterns were compared using the t test, and correlation between these expression profiles was studied using Spearman's rank-order correlation coefficient for each histological type. The level of significance chosen was fixed at 5%.
Results
Northern blot analysis of LNOX2 gene expression
Among 23 different human tissues (Fig. 1) , a high expression of an approximately 7-kb mRNA was evidenced in the thyroid gland, and a markedly lower expression in the trachea. No expression was observed in the other tissues. Colon polyA ϩ RNA, provided by CLONTECH Laboratories, Inc., were purified from tissues without mucosa.
Blast analysis of expressed sequence tags (EST) databases
GenBank "expressed sequence tags" database (dbest) was searched using the sequences of the 3Ј-untranslated region (3Ј-UTR) of LNOX1 and of LNOX2 cDNA as queries. Table  2 reports EST from normal human tissues, other than the thyroid gland, with strong or complete similarity with the 3Ј-UTR sequences of LNOX1 and LNOX2 mRNA. Blast analysis indicates that LNOX1 gene is also expressed in the cerebellum, lung, testis, and squamous epithelium of the tongue. LNOX2 gene expression is found in the uterus, colon, prostate, gall-bladder, and pancreatic islets. Figure 2 shows the LNOX1 and LNOX2 mRNA levels in 47 thyroid tissues. Figure 2A shows that, among the 5 specimens of normal tissue, LNOXI gene expression displayed variations (1-to 5-fold) and that even greater variations (1-to 11-fold) affected LNOX2 gene expression. Considerable variations of both LNOX mRNA levels were also observed among the 5 Graves' tissues (Fig. 2B), 8 toxic adenomas (Fig.  2C) , 5 multinodular goiters (Fig. 2D) , and 24 hypofunctioning adenomas (Fig. 2E) . The mean mRNA levels of LNOX1 (Fig.  3A) and of LNOX2 (Fig. 3B ) in pathological tissues were not statistically different from normal. Figure 4 shows that the expression of the two LNOX genes was significantly correlated (r ϭ 0.6; P Ͻ 0.0001) in the 47 samples. However, values corresponding to hyperfunctioning tissues were mainly distributed under the curve, reflecting a lower proportion of LNOX2 mRNA in these samples.
Expression of LNOX1 and LNOX2 mRNAs in thyroid tissues
Western blot analysis
Immunoblot analysis of membrane proteins from normal tissue was performed using purified antiserum to LNOX2 peptide. A protein with a molecular mass of 164 Ϯ 3 kDa (mean Ϯ sd, n ϭ 14) was detected in untreated membranes (Fig. 5A) . N-glycosidase F treatment of membrane proteins induced a shift of the molecular mass to 148 Ϯ 9 kDa (n ϭ 9). The 10 -20 kDa shift of the molecular mass was not increased by an additional treatment with N-glycosidase F (25 U/mL), suggesting that N-deglycosylation was maximal (not shown). Preincubation of the antibody with an excess of synthetic peptide prevented the labeling of these proteins (Fig. 5B) .
Although obtained after immunization with the L 410 -T 423 LNOX2 synthetic peptide, the antiserum also detected, as a 162 Ϯ 3 kDa (n ϭ 3) polypeptide, the recombinant human LNOX1 expressed in Cos-7 cells after transfection with pREP4 expression vector containing its full coding cDNA (Fig. 5C ). An excess of synthetic peptide again prevented labeling the of these proteins (Fig. 5D) .
Expression of LNOX proteins in thyroid tissues
In normal thyroid tissue, immunohistochemistry showed that LNOX proteins were localized at the apical membrane of thyrocytes (Fig. 6A) . The staining was heterogeneous (Fig.  6B) . Indeed, inside a given follicle, 40 -60% of follicular cells, i.e. cells that are morphologically high and likely correspond to functionally active cells, were immunostained. Positive cells were contiguous and seemed to define a particular functioning area of the follicle. In contrast, flattened cells, which are usually considered as inactive, were negative. Stromal cells, lymphocytes, intrafollicular macrophages, and vascular endothelial cells did not react with anti-LNOX antibodies.
In hyperfunctioning tissues, immunohistochemistry showed that only few follicular cells (0 -10%) were positive (Fig. 6C) . Furthermore, these positive cells were weakly immunostained for LNOX1,2.
In multinodular goiters, immunostaining was highly variable from one follicle to the other, but the average number of positive follicular cells was similar to that of normal thyroid tissues (40 -60%). LNOX immunostaining was related to the size of the follicles: the great majority of cells were positive in small follicles, and the proportion of positive cells was lower in larger follicles. As in normal tissues, immunostaining was observed in groups of contiguous high cells that seem to define a hyperfunctioning area in the follicle. Morphologically flattened cells were negative (Fig. 6E) .
In hypofunctioning adenomas, LNOX immunostaining showed a higher number of positive cells than in hyperfunctioning thyroid tissues. Immunostaining was highly variable among adenomas and seemed to be related to the size of the follicles, ranging from a weak staining of a minority of cells in macrofollicular adenomas (not shown) to an intense staining in microfollicular adenomas (Fig. 6G) . In Hü rthle cell adenomas, immunostaining was similar to that in normal tissue (Fig. 6F) .
Comparison of LNOXs and NIS immunostaining
The comparison of immunostaining for LNOXs and NIS on serial tissue sections from different pathological conditions demonstrated an inverse relationship between the number of LNOX-positive cells and of NIS-positive cells. In Graves' thyroid tissues and in toxic adenomas, the number of LNOX-positive cells was low (0 -10%) and that of NISpositive cells was high (Ͼ80%) (Fig. 6, C and D) . In contrast, in hypofunctioning microfollicular adenomas, the number of LNOX-positive cells was high, whereas the number of NISpositive cells was very low or null (Fig. 6, G 
and H).
Discussion
Previous studies have shown that the p138
Tox /LNOX2 mRNA expression was restricted to the thyroid gland in pig (12) and dog tissues, with a weak expression in dog stomach (13) , whereas LNOX1 was found only in dog thyroid (13) . In this study, Northern blot analysis was extended to 23 different human tissues. LNOX2 mRNA was present only in the thyroid gland and trachea. Expression in trachea was weak and may be attributable to a contamination by thyroid tissue. These data confirm that LNOX2 constitutes a new differentiation marker of thyrocytes. However, Northern blot studies were not sensitive enough to detect the probably low levels of LNOX2 mRNA evidenced in prostate and pancreas by a blast analysis of EST database. It is likely that only few cells from these tissues express LNOX genes. LNOX2 gene is expressed in rat colon (17) , and probably also in human colon, as attested by numerous EST isolated from this tissue. Blast analysis revealed also the presence of LNOX1 mRNA in nonthyroid tissues such as the cerebellum, lung, testis, and tongue epithelium.
The availability of a polyclonal antibody permitted us to analyze LNOX expression in various thyroid tissues. As shown by ELISA analysis, the antibody raised against LNOX2 peptide also reacted with the homologous LNOX1 peptide. It also reacted with recombinant human LNOX1 in Western blot analyses. LNOX1,2 were detected as immunoreactive proteins with an apparent molecular mass of 164 kDa; but in the absence of specific antibody, it was not possible to determine the relative proportion of each LNOX strongly stained (magnification, ϫ100). E, Immunostaining for LNOX1,2 in multinodular goiter. The staining is restricted to high active columnar follicular cells. The flattened inactive follicular cells (arrow) are not stained (magnification, ϫ250). F, Immunostaining for LNOX1,2 in a Hü rthle cells adenoma that is similar to normal tissues (magnification, ϫ250). G, Immunostaining for LNOX1,2 in a hypofunctioning microfollicular adenoma. The majority of follicular cells are strongly stained (magnification, ϫ250). H, Immunostaining for the NIS in the same hypofunctioning microfollicular adenoma as in Fig. 5G. No staining is observed (magnification, ϫ250) .
protein in thyroid tissue. Western blot analyses demonstrated that LNOX proteins are actually glycoproteins, and that N-glycosylation motifs account for 10 -20 kDa of their molecular mass. The predicted molecular mass of the unglycosylated LNOX proteins being 177 kDa (13), the glycosylated molecules should exhibit a molecular mass of at least 187-197 kDa. It is known that binding of higher amount of SDS to hydrophobic proteins than to marker proteins accelerates their relative rate of migration during electrophoresis, leading to an underestimation of their molecular mass. Because LNOX1,2 have seven hydrophobic stretches, such a mechanism may be responsible for their low apparent molecular mass in our experiments. Alternatively, a maturation or a degradation of the protein involving the release of a 20 -30 kDa peptide cannot be excluded.
The immunohistochemical study confirmed that LNOX1,2 are located at the apical pole of thyrocytes (13) . This localization is in agreement with the well-known localization of iodide organification (22) , and of the H 2 O 2 generator system (23) (24) (25) to which at least LNOX2 is likely to participate. In normal tissue, 40 -60% of follicular cells were stained and corresponded to high, columnar cells, which are usually considered as functionally active cells. In contrast, flattened cells, which are usually considered as functionally inactive, were not stained. In both multinodular goiters and in hypofunctioning adenomas, the proportion of positive cells and the intensity of staining were much higher in microfollicles usually considered as active than in macrofollicles usually considered as inactive. These data suggest that LNOX expression may be related to the functional activity of the follicle, and inside a given follicle to the functional activity of each cell.
Quantitative PCR measurements of each mRNA revealed that the levels of the two LNOX mRNAs varied in parallel, suggesting that the two genes, closely linked on chromosome 15, are regulated by similar mechanisms (Fig. 4) . However, the expression of each LNOX gene may also be more specifically modulated, as suggested by a lower proportion of LNOX2 mRNA in hyperfunctioning tissues. Although a positive effect of cAMP has been previously observed on the expression of the H 2 O 2 generator (26), of NADPH oxidase activity (27) , and recently of LNOX1 and LNOX2 mRNAs and proteins in cultured thyrocytes (12, 13, 17) , a decrease in LNOX2 mRNA level in the hyperstimulated thyroid gland of rat treated by an antithyroid drug has been reported (17) . Despite a dependent expression of all known thyroid functional genes upon cAMP stimulation, other mechanisms occur in vivo and may account for the absence of increased expression of LNOX2 mRNAs in hyperstimulated glands. Average LNOX1 and LNOX2 mRNA levels seemed to be unchanged in hyperfunctioning human tissues (Fig. 3) , in contrast to that of NIS and TPO, which are increased (28) . However, the considerable individual variations of LNOX1 and of LNOX2 mRNA levels within each group of tissues made this comparison poorly relevant. Further studies are therefore necessary to assess the consequences of hyperstimulation of human thyroid on each LNOX at the mRNA level. By contrast, the substantial decrease of LNOX immunostaining in all Graves' thyroid tissues and toxic adenoma demonstrates the existence of mechanisms that may protect hyperstimulated thyrocytes from oxidative stress resulting from an overexpression of NADPH oxidase. This is in agreement with the observation that the H 2 O 2 generator is less active in human autonomous adenomas than in normal tissue, whereas NIS and TPO gene expression is increased (29) .
